X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (29) 29
index medicus (25) 25
neuroprostanes (20) 20
humans (19) 19
neurosciences (18) 18
oxidative stress (18) 18
disease models, animal (15) 15
male (15) 15
neuroprostanes - therapeutic use (15) 15
isoprostanes (14) 14
biochemistry & molecular biology (12) 12
mice (12) 12
rats (12) 12
alzheimers-disease (10) 10
female (10) 10
brain (9) 9
analysis (8) 8
article (8) 8
in-vivo (8) 8
neuroprostanes - metabolism (8) 8
oxidative stress - drug effects (8) 8
brain - metabolism (7) 7
docosahexaenoic acid (7) 7
dose-response relationship, drug (7) 7
lipid peroxidation (7) 7
lipid-peroxidation (7) 7
neurology (7) 7
neuroprostanes - pharmacology (7) 7
analysis of variance (6) 6
antioxidants (6) 6
isoprostanes - metabolism (6) 6
lipid peroxidation - drug effects (6) 6
mice, inbred c57bl (6) 6
neurodegeneration (6) 6
apoptosis (5) 5
biomarkers (5) 5
rats, sprague-dawley (5) 5
time factors (5) 5
vitamin-e (5) 5
biomarkers - analysis (4) 4
biomarkers - metabolism (4) 4
brain - drug effects (4) 4
estrogen (4) 4
f-2-isoprostanes (4) 4
f2-isoprostanes - metabolism (4) 4
food and beverages (4) 4
gene expression regulation - drug effects (4) 4
ischemia (4) 4
life sciences (4) 4
lipids (4) 4
mice, knockout (4) 4
neurons - drug effects (4) 4
neurons - metabolism (4) 4
pharmacology & pharmacy (4) 4
[sdv]life sciences [q-bio] (3) 3
alzheimer's disease (3) 3
arachidonic-acid (3) 3
brain damage (3) 3
cerebrospinal-fluid (3) 3
chemistry, medicinal (3) 3
docosahexaenoic acids - metabolism (3) 3
enzyme inhibitors - pharmacology (3) 3
f-ring (3) 3
f2-isoprostanes - analysis (3) 3
health aspects (3) 3
inflammation (3) 3
isoprostanes - analysis (3) 3
mass spectrometry (3) 3
mice, transgenic (3) 3
middle aged (3) 3
motor activity - drug effects (3) 3
multiple-sclerosis (3) 3
nervous system diseases (3) 3
neuroprotection (3) 3
neurotoxicity (3) 3
oxidant stress (3) 3
oxidation-reduction (3) 3
oxidation-reduction - drug effects (3) 3
oxidative stress - physiology (3) 3
pediatrics (3) 3
polyunsaturated fatty acids (3) 3
prostaglandin e-2 (3) 3
reactive oxygen species (3) 3
research (3) 3
review (3) 3
rodents (3) 3
signal transduction - drug effects (3) 3
stress (3) 3
[chim.orga]chemical sciences/organic chemistry (2) 2
activation (2) 2
adult (2) 2
aged (2) 2
aged female rats (2) 2
alpha-linolenic acid (2) 2
alzheimer disease - drug therapy (2) 2
alzheimer disease - genetics (2) 2
alzheimer disease - metabolism (2) 2
alzheimer’s disease (2) 2
amyloid beta-peptides - metabolism (2) 2
animals, newborn (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Molecular Aspects of Medicine, ISSN 0098-2997, 12/2018, Volume 64, pp. 161 - 168
Journal Article
Journal of Neuroscience Research, ISSN 0360-4012, 10/2016, Volume 94, Issue 10, pp. 865 - 878
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 05/2011, Volume 117, Issue 3, pp. 388 - 402
J. Neurochem. (2011) 117, 388–402. Alzheimer’s disease (AD) is one of the most common forms of dementia in the elderly. In AD patients, β‐amyloid peptide (Aβ)... 
neuronal cells | Alzheimer’s disease | APP‐transgenic mice | pre‐synaptic proteins | reactive oxygen species | pre-synaptic proteins | APP-transgenic mice | Alzheimer's disease | PROTEIN | ALZHEIMERS-DISEASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | PARAMETERS | NEUROSCIENCES | OLIGOMERS | SUPPLEMENTATION | SCAVENGER RECEPTOR | ANTIOXIDANT | STRESS | EXPRESSION | CONSUMPTION | L-Lactate Dehydrogenase - metabolism | Cysteine - analogs & derivatives | Hydrogen Peroxide - adverse effects | Plant Extracts - pharmacology | Humans | Garlic - chemistry | Alzheimer Disease - pathology | Time Factors | Amyloid beta-Peptides - metabolism | Cysteine - pharmacology | Exploratory Behavior - drug effects | Neurons - drug effects | Neuroprostanes - therapeutic use | Disease Models, Animal | Synaptophysin - metabolism | Synapses - drug effects | Alzheimer Disease - physiopathology | Alzheimer Disease - drug therapy | Rats | Reactive Oxygen Species - adverse effects | Memory, Short-Term - drug effects | Mice, Transgenic | Gene Expression Regulation - drug effects | Amyloid beta-Protein Precursor - genetics | Animals | Analysis of Variance | Cysteine - therapeutic use | Mice | Synaptosomal-Associated Protein 25 - metabolism | Alzheimer Disease - genetics | Neuroprostanes - pharmacology | Plant Extracts - therapeutic use | Cell Line, Transformed | Proteins | Antioxidants | Medical colleges | Methyl aspartate | Cysteine | Neurosciences | Neurons | Analysis | Oxidative stress | Cell culture | Garlic | Models | Extraction processes | Rodents | Alzheimer's disease (AD) | reactive oxygen species (ROS) | transgenic mice
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 01/2011, Volume 31, Issue 1, pp. 247 - 261
Journal Article
Journal Article
CNS Neuroscience & Therapeutics, ISSN 1755-5930, 12/2018, Volume 24, Issue 12, pp. 1185 - 1195
Journal Article
Journal Article